𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis

✍ Scribed by Cinthia Farina; Stefan Wagenpfeil; Reinhard Hohlfeld

Publisher
Springer
Year
2002
Tongue
English
Weight
502 KB
Volume
249
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reliability and validity of the Self-Eff
Reliability and validity of the Self-Efficacy for Performing Energy Conservation Strategies Assessment for persons with multiple sclerosis
✍ Amber Liepold; Virgil Mathiowetz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

The purpose of the study was to determine the test-retest reliability, internal consistency, and construct validity of the Self-Efficacy for Performing Energy Conservation Strategies Assessment (SEPECSA) for persons with multiple sclerosis (MS). The current study was part of a larger study (Mathiowe

European/Canadian multicenter, double-bl
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis
✍ Giancarlo Comi; Massimo Filippi; Jerry S. Wolinsky 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

## Abstract Two prior double‐blind, placebo‐controlled, randomized trials demonstrated that glatiramer acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis (RRMS). This study was designed to determine the effect, onset, and durability of any effect of GA on dis